Piper Sandler Raises Bausch Health Companies (NYSE:BHC) Price Target to $9.00
Bausch Health Companies (NYSE:BHC – Free Report) had its price target hoisted by Piper Sandler from $7.00 to $9.00 in a research report released on Monday, BayStreet.CA reports. Piper Sandler currently has a neutral rating on the stock. Other equities research analysts have also recently issued research reports about the company. StockNews.com upgraded Bausch Health […]